Gapping up
In reaction to earnings/guidance:
- TAP +1.9% (also re-established dividend) WAL +1.8%, AA +1.3%
Other news:
- MGI +10.8% (FT discusses rumors that private equity firm Advent might be interested in MGI)
- CLXT +10.4% (names new CEO)
- MRNA +7.9% (to join S&P 500)
- HCM +5.5% (submits MAA to EMA for Surufatinib)
- IBIO +4.6% (announces results from preclinical studies of COVID-19 vaccine candidate IBIO-202)
- FUBO +4.5% (fuboTV and Cordish ink market access agreement for Fubo Sportsbook in PA)
- PFDR +3.7% (to combine with ServiceMax)
- ASTR +2.2% (stock offering)
- ORGN +1.3% (stock offering)
- HAL +1.1% (signs contract with Petrofac)
- MEOH +1.1% (Methanex and Mitsui O.S.K agree on commercial terms for a strategic partnership)
- ALK +1% (says it recorded positive pretax margin in June)
Analyst comments:
- DNOW +2.9% (upgraded to Buy from Hold at Stifel)
- HNST +2.4% (upgraded to Buy from Hold at Loop Capital)
- CTAS +1.3% (upgraded to Outperform from Neutral at Robert W. Baird)
- CMI +1.1% (upgraded to Outperform from Market Perform at Cowen)
- ET +1.1% (upgraded to Outperform from Peer Perform at Wolfe Research)